 |
|
Hepatitis B Reactivation During Adjuvant Anthracycline-Based Chemotherapy in Patients with Breast Cancer: A Single Institution's Experience
Min Kyoung Kim, Jin Hee Ahn, Sung-Bae Kim, Young-Suk Im, Soon Im Lee, Sei-Hyun Ahn, Byung Ho Son, Gyungyub Gong, Hak-Hee Kim, Woo Kun Kim
Korean J Intern Med. 2007;22(4):237-243. Published online 2007 Dec 20 DOI: https://doi.org/10.3904/kjim.2007.22.4.237
|
|
Citations to this article as recorded by
 Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?
Sama Anvari, Keith Tsoi
Journal of Clinical Medicine.2024; 13(2): 393. CrossRef Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis
Natee Deepan, Soe Thiha Maung, Pakanat Decharatanachart, Roongruedee Chaiteerakij
Seminars in Oncology.2024;[Epub] CrossRef Reactivation of Hepatitis B Virus among Malignancy Patients Undergoing Chemotherapy: A Prospective Cohort Study
Mohit Sethia, Rahul Jain, Vani Singh, Santosh Singh, Saurabh Mahajan, Harshul Jain, Jyoti Yadav, A. K. Yadav
Journal of Marine Medical Society.2024;[Epub] CrossRef APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok,
Hepatology International.2021; 15(5): 1031. CrossRef Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B
Grace Lai‐Hung Wong, Becky Wing‐Yan Yuen, Henry Lik‐Yuen Chan, Yee‐Kit Tse, Terry Cheuk‐Fung Yip, Kelvin Long‐Yan Lam, Grace Chung‐Yan Lui, Vincent Wai‐Sun Wong, Francesco Negro
Liver International.2019; 39(2): 271. CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93. CrossRef Screening and Prophylaxis to Prevent Hepatitis B Reactivation
Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G.
Clinics in Liver Disease.2019; 23(3): 521. CrossRef Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required?
Alessandro Federico, Giuseppina Brancaccio, Marcello Dallio, Patrizia Iodice, Alessio Fabozzi, Salvatore Del Prete, Fortunato Ciardiello, Carmela Loguercio, Giovanni Battista Gaeta
Digestive and Liver Disease.2017; 49(2): 197. CrossRef Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta‐analysis of prophylaxis management
Z. Liu, L. Jiang, G. Liang, E. Song, W. Jiang, Y. Zheng, C. Gong
Journal of Viral Hepatitis.2017; 24(7): 561. CrossRef Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions
Rohit Loomba, T. Jake Liang
Gastroenterology.2017; 152(6): 1297. CrossRef Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large‐scale, big‐data intelligence platform–based analysis from an endemic area
Jia‐Wei Lv, Yu‐Pei Chen, Xiao‐Dan Huang, Guan‐Qun Zhou, Lei Chen, Wen‐Fei Li, Ling‐Long Tang, Yan‐Ping Mao, Ying Guo, Rui‐Hua Xu, Jun Ma, Ying Sun
Cancer.2017; 123(18): 3540. CrossRef Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
Soheil Tavakolpour, Seyed Moayed Alavian, Shahnaz Sali
Hepatitis Monthly.2016;[Epub] CrossRef Prevention of Hepatitis B reactivation in the setting of immunosuppression
Venessa Pattullo
Clinical and Molecular Hepatology.2016; 22(2): 219. CrossRef Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
C.S. Voican, O. Mir, P. Loulergue, M. Dhooge, C. Brezault, J. Dréanic, S. Chaussade, S. Pol, R. Coriat
Annals of Oncology.2016; 27(12): 2172. CrossRef The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
Bahiddin Yilmaz, Dilek Erdem, Fatih Teker, Ibrahim Goren, Beytullah Yildirim, Engin Kut, Derya Sarikaya, Memis H Atay, Idris Yucel
Journal of International Medical Research.2016; 44(3): 627. CrossRef HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT
Ha Ra Gu, Dong-Yeop Shin, Hong Seok Choi, Chae Ho Moon, Su Cheol Park, Hye Jin Kang
Blood Research.2015; 50(1): 51. CrossRef The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: A meta-analysis
Jun-Ying Liu, Yun-Jian Sheng, Xiang-Chun Ding, Hui Tang, Shi-Wen Tong, Da-Zhi Zhang, Zhi Zhou, Peng Hu, Yong Liao, Hong Ren, Huai-Dong Hu
Journal of the Formosan Medical Association.2015; 114(2): 164. CrossRef mRNA expression of glucocorticoid receptor and serological and virological markers of chronic hepatitis B
BING MEI, YONGLING CHEN, WEIJIA LIU, LINYUN LI, CHANGFU WANG
Molecular Medicine Reports.2015; 11(3): 2215. CrossRef Screening for Hepatitis B in Patients with Lymphoma
Jonathan Ramirez, Anupama Thadareddy Duddempudi, Moazzam M. Sana, Syed S. Hasan, Mario De Los Santos, Juhee Song, Ying Fang-Hollingsworth, Sandeep S. Gupta, Dawn M. Sears
Baylor University Medical Center Proceedings.2015; 28(4): 438. CrossRef Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013
Hwi Young Kim
World Journal of Gastroenterology.2014; 20(40): 14581. CrossRef Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic
Tsutomu Nishida, Naoki Hiramatsu, Masao Mizuki, Izumi Nagatomo, Hiroshi Kida, Keiko Tazumi, Shinichiro Shinzaki, Masanori Miyazaki, Takayuki Yakushijin, Tomohide Tatsumi, Hideki Iijima, Shinichi Kiso, Tatsuya Kanto, Masahiko Tsujii, Tetsuo Takehara
Hepatology Research.2013; 43(4): 339. CrossRef Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis
Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila
Critical Reviews in Oncology/Hematology.2013; 87(1): 12. CrossRef Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
W H Y Ling, P P Soe, A S L Pang, S-C Lee
British Journal of Cancer.2013; 108(10): 1931. CrossRef Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
M. Ikeda
Japanese Journal of Clinical Oncology.2013; 43(1): 8. CrossRef Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
Hepatology International.2013; 7(2): 316. CrossRef Management of hepatitis B reactivation in patients receiving cancer chemotherapy
Yi-Wen Huang, Raymond T. Chung
Therapeutic Advances in Gastroenterology.2012; 5(5): 359. CrossRef Updated Longitudinal Data on Acute Exacerbation of Chronic Hepatitis B in Patients With Breast Cancer Receiving Anthracycline-based Adjuvant Chemotherapy: Therapeutic vs. Pre-emptive Use of Lamivudine
B. S. Sohn, J. H. Ahn, K. H. Jung, S.-H. Ahn, B. H. Son, G. Gong, S.-B. Kim
Japanese Journal of Clinical Oncology.2011; 41(9): 1059. CrossRef Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine
Shih-Hung Tsai, Ming-Shen Dai, Jyh-Cherng Yu, Ching-Liang Ho, Yeu-Chin Chen, Yi-Ying Wu, Ping-Ying Chang, Woei-Yau Kao, Tsu-Yi Chao
Supportive Care in Cancer.2011; 19(11): 1779. CrossRef Republished paper: Managing HBV in patients with impaired immunity
Karsten Wursthorn, Heiner Wedemeyer, Michael P Manns
Postgraduate Medical Journal.2011; 87(1025): 223. CrossRef Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management
John S Lubel, Peter W Angus
Journal of Gastroenterology and Hepatology.2010; 25(5): 864. CrossRef How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation
Raymond Liang
Blood.2009; 113(14): 3147. CrossRef
|